914 material Form 8-K filings that 746 companies we cover made with the SEC in June 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
On June 24, 2026, Allegiant Travel Company issued $650 million of 7.125% senior secured notes due July 1, 2031, and used part of the proceeds to buy $377.5 million of its 7.25% notes due 2027 tendered in a tender offer. The new notes are secured by substantially all company and guarantor assets except aircraft, aircraft engines and real property, and the company must keep at least $300.0 million of liquidity at each quarter end. Shareholders should note the added secured debt and the restrictive terms, while the filing does not give total debt or cash balances.
$650.0 million of 7.125% notes issued June 24, 2026, maturing July 1, 2031, with cash interest due January 1 and July 1 starting January 1, 2027
$377,534,000 of 7.25% notes due 2027 purchased on June 24, 2026, at total consideration of $1,005.00 per $1,000 principal; $25,465,000 remain and are expected to be redeemed in third quarter 2026
Notes are secured by substantially all assets excluding aircraft, aircraft engines and real property; a $300.0 million minimum liquidity covenant applies, with 2.0% additional interest if breached
Existing 2027 notes indenture amended to remove most restrictive covenants and cut the redemption notice period from 30 days to 3 business days
The FDA approved Viridian Therapeutics' Lumvoa (veligrotug-vvze) for thyroid eye disease regardless of disease activity or duration, and the company plans to launch it immediately. The approval is Viridian's first FDA-approved product and first commercial product, a milestone that moves the company from development toward sales.
FDA approval announced June 26, 2026; Lumvoa is the first TED treatment with labeling covering both active and chronic TED
Launch planned immediately; physicians can prescribe Lumvoa tomorrow, per the press release
Lumvoa is given as five intravenous infusions over 12 weeks; infusion reactions reported in about 9% of patients
Conference call and webcast scheduled Monday, June 29, 2026 at 8:00 a.m. ET
Liquidity Services entered into a Fourth Amendment to its credit agreement with Wells Fargo Bank on June 22, 2026, extending the agreement's term from March 31, 2027 to March 31, 2028. All other terms remain unchanged, according to the filing. The extension pushes out the maturity of the company's credit facility by one year, which is routine maintenance of financing arrangements rather than a change in terms.
Amendment dated June 22, 2026 with lender Wells Fargo Bank, National Association
Credit agreement term extended from March 31, 2027 to March 31, 2028
All other terms and conditions remain in full force and effect without waiver or modification
W. R. Berkley said Executive Vice President Lucille Sgaglione will resign as an executive officer effective June 30, 2026. She will continue part-time as Senior Advisor, with compensation to be adjusted for the new role. Her outstanding long-term incentive awards will be handled under their existing award agreements.
Lucille Sgaglione resigns as Executive Vice President effective June 30, 2026
She will continue to serve part-time as Senior Advisor
Compensation to be adjusted for the advisory role; long-term incentive awards follow existing agreements
Akari Therapeutics amended its securities purchase agreement on June 23, 2026, combining its second and third closings into one. On June 26, 2026, it issued the remaining 980,395 ADSs, or prefunded warrants in lieu of them, completing the private placement. Delivery of the Series H, I and J warrants depends on shareholder approval at the annual general meeting on June 30, 2026.
Offering originally covered 1,470,588 unregistered ADSs or prefunded warrants, funded in three tranches
First closing occurred May 27, 2026; the second and third closings were combined into one on June 26, 2026
Remaining 980,395 ADSs or prefunded warrants were issued on the combined closing date
Series H, I and J warrants are contingent on shareholder approval at the June 30, 2026 annual general meeting
James E. Davison notified the board of Genesis Energy's general partner of his retirement from the board, effective June 26, 2026. The filing says his decision was not due to any disagreement with the company on operations, policies or practices. The filing does not name a successor or describe any financial effect.
James E. Davison retired from the board of the general partner, effective June 26, 2026
The filing states no disagreement with Genesis Energy on operations, policies or practices
The filing names no replacement director and gives no financial figures
Phibro Animal Health said Daniel (Dani) Bendheim will become Chief Executive Officer and President effective July 1, 2026, under a new employment agreement with a $850,000 base salary. He also received a grant of 300,000 performance-based restricted stock units that vest only if the company's 90-day average stock price reaches $70 to $100 by June 30, 2031.
Bendheim's base salary is $850,000 annually, with a target bonus of 50% of base salary.
The 300,000 RSUs vest in 25% increments tied to a 90-day average stock price from $70 to $100 or above, with no vesting below $70.
Severance includes six months of base salary on death or disability and up to 18 months of company-subsidized COBRA coverage on termination without Cause or resignation.
Applied Digital's subsidiary APLD Intermediate HoldCo entered into an incremental agreement that raises the revolving credit commitments under its May 29, 2026 credit agreement to $430.0 million, maturing May 28, 2029. The company also amended its Preferred Equity Purchase Agreement to lift the Series G Convertible Preferred Stock commitment from $1.59 billion to $2.0 billion, adding capacity for future equity issuance to investors.
Secured revolving credit facility increased to $430.0 million, maturing May 28, 2029, with up to $120.0 million more available for a total of $550.0 million
Credit facility priced at Term SOFR plus 2.25% or base rate plus 1.25%, guaranteed by the company and restricted subsidiaries
PEPA Series G Convertible Preferred Stock commitment raised from $1,590,000,000 to $2,000,000,000 under the Sixth Amendment dated June 26, 2026
On June 26, 2026, Automatic Data Processing entered a $5.7 billion 364-day credit agreement and a $3.5 billion five-year credit agreement with a group of lenders. The new facilities replaced a $4.55 billion 364-day facility and a $3.5 billion five-year facility, both of which were terminated on the same date, and the company says their other terms are substantially similar to the facilities they replaced.
364-Day Facility of $5.7 billion: commitments expire June 25, 2027, with an option to extend maturity to June 25, 2028.
Five-Year Facility of $3.5 billion: matures June 26, 2031, and includes an accordion feature that can raise the commitment by $500 million to $4 billion.
Replaces a $4.55 billion 364-day facility entered June 27, 2025 and a $3.5 billion five-year facility entered June 28, 2024.
Commitment fee is 0.0175% per year on the 364-Day Facility and 0.04% to 0.10% on the Five-Year Facility, based on the issuer rating; borrowings may be used for general corporate purposes.
California Resources completed a $550 million private offering of 7.250% senior unsecured notes due January 15, 2035. The company said it intends to use the proceeds, together with cash on hand and or revolver borrowings, to redeem all $550 million of its 8.250% notes due 2029 at 104.125% of principal plus accrued interest. The refinancing swaps one $550 million debt issue for another with a later maturity and a lower coupon, though the filing does not state any effect on annual interest expense.
Notes: $550 million, 7.250% senior unsecured, maturing January 15, 2035; interest payable January 15 and July 15, starting January 15, 2027
Redemption: all $550 million of 8.250% notes due 2029, at 104.125% of principal plus accrued interest; the redemption closed June 26, 2026
Optional redemption by the company generally begins July 15, 2029; change of control repurchase price is 101% of principal
Indenture filed as Exhibit 4.1; trustee is Wilmington Trust, National Association
Harley-Davidson said its Chief Legal, Compliance and Corporate Affairs Officer and Corporate Secretary, Paul Krause, will step down from that role effective June 29, 2026, and move to an advisory role until September 1, 2026, when he will leave the company. Gayle Littleton will take over the same role and the Corporate Secretary position on June 29, 2026. The change affects a senior legal and governance post, but the filing gives no financial figures or operating impact.
Paul Krause ceases as Chief Legal, Compliance and Corporate Affairs Officer and Corporate Secretary effective June 29, 2026
Krause advises through September 1, 2026, then exits and is entitled to benefits under the Company's Severance Plan
Gayle Littleton joins as Chief Legal, Compliance and Corporate Affairs Officer and Corporate Secretary effective June 29, 2026
Fortrea appointed Jason Knoblauch as chief financial officer, effective July 6, 2026, succeeding Jill McConnell, who steps down on that date but will stay with the company for a transition period. The company said the change does not reflect any disagreement with Ms. McConnell over financial reporting, internal controls, or auditing. Fortrea also reiterated its full-year 2026 guidance, which it did not change.
Jason Knoblauch, 45, becomes CFO effective July 6, 2026; he previously was CFO at Clario, from August 2023 to June 2026.
Offer letter dated June 22, 2026 sets a $570,000 base salary, an 85% target bonus, and a $1,250,000 cash inducement paid $500,000 at start and $750,000 after one year.
Planned inducement equity of about $2,300,000 in RSUs and $1,700,000 in PSUs, anticipated in September 2026, capped at 400,000 shares combined.
2026 guidance reiterated: revenues of $2,550 million to $2,650 million and adjusted EBITDA of $190 million to $220 million.
Iron Mountain completed a private offering of $1.5 billion in 6.250% senior notes due January 15, 2035, sold at 100% of par, with net proceeds of about $1,481.8 million. The company plans to use the proceeds mainly to repay outstanding borrowings under its revolving credit facility, with any remainder for general corporate purposes, so shareholders should note the added long-term debt.
$1.5 billion aggregate principal of 6.250% senior notes, sold at 100.00% of par
Net proceeds of approximately $1,481.8 million after discounts and estimated expenses
Proceeds intended to repay all or part of revolving credit facility borrowings and pay fees
Interest payable January 15 and July 15, first payment January 15, 2027; notes mature January 15, 2035
Bristow Group agreed on June 23, 2026 to buy Berry Aviation, a special missions and government aviation provider, for $105 million in cash, subject to adjustments. The company also said it is pursuing a sale of its Norway offshore energy services business, and that the Berry deal would be neutral to its 2025 EBITDA on a pro forma basis with that exit.
Purchase price is $105 million in cash, subject to adjustment for working capital, cash, indebtedness and transaction expenses
Berry Aviation had 2025 total revenues of approximately $108 million and 2025 EBITDA of approximately $12 million, per the investor slides
Closing is expected in the third quarter of 2026 per the press release; the 8-K says the second half of 2026
Bristow intends to fund the deal with cash on hand; the Norway sale timing and structure remain subject to market conditions
Goodyear said Chief Financial Officer Christina Zamarro will step down effective June 30, 2026 and leave the company on July 10 to pursue another opportunity. Scott Deakin, 60, a former CFO of Gypsum Management & Supply, Inc., will serve as interim Executive Vice President and CFO from July 1 while the company searches for a permanent successor. The filing states that her departure is not related to the company's financial or operating results or to any disagreements over accounting or reporting.
Christina Zamarro steps down as EVP and CFO effective June 30, 2026, and leaves the company July 10, 2026.
Scott Deakin, 60, becomes interim EVP and CFO effective July 1, 2026, and will be the principal financial officer until a permanent CFO is appointed.
Deakin will receive a salary of $30,000 per week, a bonus of $5,000 per week based on weeks worked, and restricted stock units with a $500,000 grant date value.
Deakin was CFO of Gypsum Management & Supply, Inc. from 2019 to 2026; the company is conducting a comprehensive search for a permanent CFO.
Ascent Solar Technologies said it has increased the amount it can sell under its at-the-market offering agreement with H.C. Wainwright & Co. by $15,000,000 of shares, with sales to be made under a new shelf registration statement and prospectus supplement dated June 26, 2026. The filing says the number of shares sold and proceeds are not determinable at this time, and the company plans to use any proceeds for general and administrative expenses and general corporate purposes, which means existing shareholders could face dilution if shares are sold.
Additional capacity under the ATM Agreement: $15,000,000 of shares, under a prospectus supplement dated June 26, 2026.
Since May 16, 2024, the company has sold 1,804,444 shares for gross proceeds of approximately $12,657,279.56.
Shares outstanding were 9,816,431 as of June 26, 2026.
H.B. Fuller and the board of Advanced Medical Solutions Group plc (AMS) agreed terms on a recommended cash offer, to be implemented through a UK court-sanctioned scheme of arrangement. The company has arranged bridge credit agreements of up to $2,086,713,188 (secured) and $917,000,000 (unsecured) to fund the deal and refinance debt, and expects completion by the end of calendar 2026, which would add new borrowings for shareholders to weigh against the strategic growth case.
AMS shareholders will receive 285 pence in cash per AMS share; the press release cites a total enterprise value of £715 million.
Secured Bridge Credit Agreement of up to $2,086,713,188 and Unsecured Bridge Credit Agreement of up to $917,000,000, both with Goldman Sachs Bank USA; loans would mature 364 days after closing.
Completion is expected by the end of calendar 2026, subject to AMS shareholder approval, High Court sanction, regulatory approvals, and a Long-Stop Date of June 25, 2027.
Company expects approximately $55 million in combined run-rate revenue and cost synergies by 2031.
Cboe Global Markets, as guarantor, signed an amended and restated agreement extending the credit facility of its subsidiary Cboe Clear Europe N.V. until June 25, 2027. The aggregate commitment remains €1.2 billion, or €1.7 billion after the accordion increase, and the filing describes the changes as routine updates to the facility rather than a change in size.
Facility term extended to June 25, 2027
Aggregate commitment maintained at €1.2 billion; €1.7 billion including the accordion increase
Bank of America Europe DAC serves as co-ordinator and facility agent; Citibank N.A., London Branch, as security agent
Agreement dated June 23, 2026, to be effective June 26, 2026
Firefly Neuroscience and an accredited investor mutually agreed in writing on June 25, 2026 to terminate a securities purchase agreement dated May 6, 2026. The deal would have sold up to 666,667 units at $1.50 per unit, for up to $1,000,000 in gross proceeds. The filing does not give a reason for the termination, and the company does not say whether it will seek other financing.
Purchase agreement dated May 6, 2026 covered up to 666,667 units at $1.50 per unit
Aggregate gross proceeds of up to $1,000,000 were contemplated
Termination mutually agreed in writing on June 25, 2026, effective as of that date
Filing made under Item 1.02 and signed by CEO Greg Lipschitz on June 26, 2026
VeriSign completed a registered offering of $550 million aggregate principal amount of 5.100% Senior Notes due July 15, 2031, on June 26, 2026. The notes are senior unsecured obligations and carry covenants limiting liens, sale and leaseback transactions, and certain mergers or asset sales, which add new debt that shareholders will need to service.
Principal amount of $550 million, interest at 5.100% per year, maturing July 15, 2031
Interest paid semi-annually on January 15 and July 15, starting January 15, 2027
Notes rank equally with the company's other senior indebtedness; change of control repurchase at 101% of principal plus accrued interest
Issued under a June 8, 2021 base indenture and a Third Supplemental Indenture dated June 26, 2026 with U.S. Bank Trust Company as trustee
Integer Holdings said its President of Cardiac Rhythm Management & Neuromodulation, Jim Stephens, will become Executive Vice President, Special Projects, effective June 29, 2026. The new role is set to end March 31, 2027, and he will not receive a 2027 short-term or long-term incentive award. The filing is a leadership transition with limited direct financial figures, but it removes a business unit president from his current role.
Jim Stephens moves from President, Cardiac Rhythm Management & Neuromodulation to Executive Vice President, Special Projects, effective June 29, 2026.
The new role ends on March 31, 2027, unless terminated earlier by Mr. Stephens or the Company.
Mr. Stephens will not be eligible for a 2027 short-term or long-term incentive award.
If a change of control occurs on or before March 31, 2027 and he remains employed through that date, his separation will be treated as a termination without Cause under his Change of Control Agreement dated May 22, 2026.
HA Sustainable Infrastructure Capital issued $1,000,000,000 of 5.950% green senior unsecured notes due July 15, 2033, on June 24, 2026, in a private offering to qualified institutional buyers and non-U.S. investors. The company plans to use the net proceeds to temporarily repay borrowings under its credit facility or commercial paper programs, then fund eligible green projects, which adds debt while refinancing shorter-term borrowings.
Principal: $1,000,000,000 of 5.950% green senior unsecured notes, issued June 24, 2026
Interest paid semi-annually on January 15 and July 15, starting January 15, 2027; maturity July 15, 2033
Change of control repurchase at 101% of principal plus accrued interest; optional redemption available before May 15, 2033 at make-whole price
Company intends to register the notes with the SEC via an exchange offer, with additional interest payable if registration obligations are missed
Kroger said Chairman Ronald L. Sargent will cease serving as a Company employee effective July 1, 2026, and will continue as Non-Executive Chairman of the Board, with updated director pay starting the same day. At the June 25, 2026 annual meeting, shareholders elected all ten directors, approved executive compensation on an advisory basis, ratified PricewaterhouseCoopers LLP as auditor, approved a revised long-term incentive plan, and rejected a shareholder proposal on GHG emissions reductions.
Effective July 1, 2026, Ronald L. Sargent (Chairman since March 2025) ceases to be an employee and continues as Non-Executive Chairman.
From July 1, 2026, each non-employee director receives a $115,000 annual cash retainer and annual incentive shares valued at about $215,000; Sargent also gets about $250,000 in annual incentive shares for chairman service.
Sargent received 468,967,642 votes for and 23,737,119 against in his director election.
The GHG emissions shareholder proposal was rejected, with 85,776,050 for and 404,190,678 against.
FedEx Freight Holding's board committee approved a transition-year cash incentive plan for June 1 to December 31, 2026, a long-term equity program for 2026 to 2028, and spin-off-related bonuses and stock awards for executives. The filing also adopts a new equity award retirement policy, effective June 24, 2026, for awards granted on or after the spin-off.
Chief Executive John A. Smith's target cash incentive is 175% of prorated base salary; his long-term incentive target is 450% of annual base salary.
Performance measures include adjusted consolidated operating income for the cash plan, and adjusted free cash flow and adjusted earnings per share for long-term awards.
Spin-off RSUs with a $1,000,000 target value go to Mr. Smith, and Chief Financial Officer Marshall W. Witt receives a $585,000 cash bonus tied to the spin-off under his offer letter.
The awards are granted June 29, 2026, following the June 1, 2026 spin-off from FedEx Corporation.
Atara Biotherapeutics said its chief accounting officer, Yanina Grant-Huerta, will leave effective July 17, 2026. The board appointed Kevin G. Sarney, a consultant from Charles River CFO, Inc., as interim chief financial officer effective June 26, 2026, and he will also serve as principal accounting officer. The change in its top finance roles is notable for shareholders because it comes through a consulting arrangement rather than a permanent hire.
Yanina Grant-Huerta, Chief Accounting Officer, was notified June 22, 2026 that her employment ends effective July 17, 2026.
Kevin G. Sarney appointed interim chief financial officer effective June 26, 2026, serving as principal financial and principal accounting officer.
Sarney's services are provided under a consulting agreement with Charles River CFO, Inc.; the Company pays an agreed hourly rate and Sarney receives no direct compensation from the Company.
The consulting agreement can be terminated by either party on 30 days written notice.
Robinhood's Board appointed Dara Bazzano, its Chief Accounting Officer since April 2026, as principal accounting officer effective June 25, 2026. CFO Shiv Verma gave up the principal accounting officer role but remains CFO and principal financial officer. Her compensation is unchanged from the terms disclosed in the filing.
Dara Bazzano, age 58, appointed principal accounting officer effective June 25, 2026
Shiv Verma ceased to be principal accounting officer; he continues as CFO and principal financial officer
Soligenix filed a prospectus supplement on June 26, 2026, raising the maximum aggregate offering amount under its At Market Issuance Sales Agreement with Rodman & Renshaw LLC by $2,500,000. The company previously sold approximately $6,234,000 of shares under prior supplements covering up to $6,406,000. The filing makes additional shares available for sale, which could add to the number of outstanding shares and dilute existing shareholders.
Maximum offering under the Sales Agreement increased by an additional $2,500,000 via a prospectus supplement filed June 26, 2026
Previously sold approximately $6,234,000 of common stock under prior supplements covering up to $6,406,000
Sales Agreement dated January 23, 2026, with Rodman & Renshaw LLC; legal opinion filed as Exhibit 5.1
BriaPro Therapeutics, a subsidiary of BriaCell Therapeutics, filed unaudited financial statements for the three and nine months ended April 30, 2026, with Canadian regulators. The nine-month net loss rose to $712,236 from $519,804 a year earlier, and the filing states a material uncertainty about the company's ability to continue as a going concern, with BriaCell as its only stated financing source until it raises more capital.
Nine-month net loss of $712,236 versus $519,804 for the same period a year earlier; three-month net loss narrowed to $240,005 from $286,619
Cash of $299,950 at April 30, 2026, including a $300,000 related-party advance from BriaCell; negative working capital of $1,937,495
Amounts owed to BriaCell group companies totaled $2,093,345; the monthly service fee was reduced from $20,000 to $5,000 effective April 30, 2026
On March 31, 2026, the company acquired the sCD80 license from BriaCell for 23,972,589 common shares valued at $846,532
At its June 25, 2026 annual meeting, Myomo stockholders approved raising the company's authorized common stock to 100,000,000 shares and adding 1,833,000 shares to the 2018 Stock Option and Incentive Plan. Stockholders also elected Paul R. Gudonis and Thomas F. Kirk as Class III directors and approved the other proposals, including an advisory say-on-pay vote. The share increases matter to existing holders because they expand the shares the company can issue, though the filing does not state the prior authorized share count.
Charter amendment raising authorized common stock to 100,000,000 shares took effect on filing with Delaware on June 25, 2026; votes: 20,723,545 for, 3,090,849 against, 146,921 abstain.
Plan amendment adds 1,833,000 shares; votes: 10,815,266 for, 3,676,078 against, 938,413 abstain.
Paul R. Gudonis (15,145,277 for) and Thomas F. Kirk (14,333,271 for) elected as Class III directors with terms expiring in 2029.
Advisory say-on-pay vote: 13,715,583 for, 696,112 against, 1,018,062 abstain; CBIZ CPAs P.C. ratified as auditor for fiscal 2026.
Ark Restaurants said a New York court on June 18, 2026 granted it summary judgment on its breach of contract claim over the Bryant Park Grill lease and the related right of first lease for the Bryant Park Café, with money damages to be set at a later trial. The court also ruled against the company on ejectment and use and occupancy claims for the Café and The Porch, and the company says it will appeal the adverse portions, which would automatically stay eviction while the appeal is pending. The company says the dispute has had and is expected to continue to have a material adverse impact on its business and results.
June 18, 2026: court granted Ark summary judgment on breach of contract for the Bryant Park Grill lease and related right of first lease for the Bryant Park Café
Court did not grant specific performance and did not preclude the Landlord's ejectment claim; damages for the Grill to be determined at a future trial
Court ruled for the Landlord on ejectment, use and occupancy, and breach of contract for the Café and The Porch; the Landlord may seek use and occupancy damages at trial
Company intends to file a Notice of Appeal, which would stay eviction pending appeal; the court will set the amount of the required undertaking
Advance Auto Parts said Executive Vice President and Chief Human Resources Officer Kristen L. Soler is leaving to pursue other opportunities. She is expected to serve in an advisory capacity through July 10, 2026, and will receive payment under the termination without due cause provision of her employment agreement. The filing gives no successor name and no payment amount.
Kristen L. Soler, EVP and Chief Human Resources Officer, is leaving the company
Advisory capacity effective June 26, 2026, through July 10, 2026
Payment made under the termination without due cause provision of her employment agreement; amount not disclosed
Worthington Enterprises reported fourth-quarter fiscal 2026 results for the quarter ended May 31, 2026, with net sales up 17% to $371 million, driven largely by acquisitions, while adjusted EBITDA fell to $83.5 million from $85.1 million. For the full fiscal year, adjusted EBITDA rose 12% to $296 million and adjusted earnings per share rose 9% to $3.37. The company also disclosed a June 22, 2026 retention award of 25,000 performance shares each to its chief financial officer, general counsel and two segment presidents.
Q4 net sales were $371 million, up 17% from $318 million; organic growth was 3%.
Q4 adjusted EBITDA was $83.5 million versus $85.1 million a year earlier; adjusted earnings were $0.97 per share versus $1.06.
Full-year fiscal 2026 adjusted EBITDA rose 12% to $296 million; net debt was $278 million at May 31, 2026.
On June 22, 2026, the compensation committee awarded 25,000 performance shares each to Colin J. Souza (CFO), Patrick J. Kennedy, Steven M. Caravati and James R. Bowes.
REalloys Inc. closed a private placement on June 26, 2026, selling 7,017,540 shares of common stock at $14.25 per share for gross proceeds of approximately $100 million, before placement agent fees and offering expenses. The company will use the net proceeds for working capital and general corporate purposes, and it has agreed to register the resale of the shares, which adds new shares that could dilute existing shareholders.
Sold 7,017,540 shares of common stock at $14.25 per share, for gross proceeds of approximately $100 million
Closed on June 26, 2026, after the purchase agreement was signed on June 24, 2026
Clear Street LLC was the sole placement agent; net proceeds will go to working capital and general corporate purposes
Company agreed to file a registration statement to register the resale of the shares
Stryker filed an 8-K to recast its consolidated financial statements for the three years ended December 31, 2025, to reflect a reorganization that created the Ortho Tech business. The company states that the recast is not a restatement and does not amend its audited financial statements. The company will continue to report two segments, MedSurg and Neurotechnology, and Orthopaedics.
Ortho Tech combines orthopaedic instruments from the Instruments business with Mako and enabling technologies from Other Orthopaedics.
Ortho Tech 2025 net sales were $2,770 million, up 11.8% as reported.
The filing covers 2023, 2024 and 2025, with the recast presented in Exhibit 99.1.
The filing does not update MD&A; more current information is in the Form 10-Q for the quarter ended March 31, 2026.
Southern Peru Copper Corporation, a Southern Copper subsidiary, said it raised $1.25 billion through a New York bond offering, mainly to develop the Tía María copper project in Peru. The bonds pay 5.35% annually and mature in 2036, and the project is expected to begin operations in the third quarter of 2027.
Bonds raised $1.25 billion in a New York market offering, announced June 24, 2026
Bonds pay an annual interest rate of 5.35% until maturity in 2036
Tía María has an annual capacity of 120,000 metric tons of refined copper and a total capital budget of $1.8 billion, of which $948 million is already committed
Apogee Enterprises reported first-quarter fiscal 2027 results, with net sales down 1.1% to $342.7 million on lower volume, while diluted earnings per share swung to $0.54 from a loss of $0.13 a year earlier. The company reaffirmed its fiscal 2027 guidance and said the pending Kalwall acquisition remains on track for an early July close.
Net sales were $342.7 million, down 1.1% from $346.6 million, driven by lower volume partly offset by favorable pricing.
Diluted EPS was $0.54 versus a loss of $0.13; adjusted diluted EPS was $0.57 versus $0.56.
Adjusted EBITDA fell 6.6% to $32.1 million, and adjusted EBITDA margin declined to 9.4% from 9.9%.
Fiscal 2027 guidance was reaffirmed: net sales of $1.38 billion to $1.43 billion and adjusted diluted EPS of $2.70 to $3.25, excluding Kalwall.
Cineverse reported fourth-quarter revenue of $26.0 million, up 67% from a year earlier, largely from the Giant Worldwide and IndiCue acquisitions, which contributed $11.6 million in their first partial quarter. For the full fiscal year ended March 31, 2026, revenue fell 16% to $65.7 million and the company posted a net loss attributable to common stockholders of $9.2 million, or $0.49 per diluted share, compared with net income of $3.2 million, or $0.16 per diluted share, a year earlier. The company reaffirmed its fiscal 2027 guidance of $115 million to $120 million in revenue and $10 million to $20 million in Adjusted EBITDA.
Q4 FY 2026 revenue of $26.0 million versus $15.6 million in Q4 FY 2025; Q4 net income attributable to common stockholders of $1.1 million, or $0.05 per diluted share
FY 2026 revenue of $65.7 million versus $78.2 million, with the decline tied to the prior-year Terrifier 3 comparison
FY 2026 net loss attributable to common stockholders of $(9.2) million, or $(0.49) per diluted share, versus net income of $3.2 million in FY 2025; Adjusted EBITDA of $(3.4) million versus $13.9 million
Fiscal 2027 guidance reaffirmed: revenue of $115 million to $120 million and Adjusted EBITDA of $10 million to $20 million; cash and cash equivalents were $3.4 million as of March 31, 2026
Expand Energy said Vice President – Accounting & Controller Gregory M. Larson informed the company on June 23, 2026 of his intention to resign, and that the resignation was not due to any disagreement on operations, policies or practices. Executive Vice President and CFO Marcel Teunissen has taken on the principal accounting officer duties on an interim basis while the company searches for a permanent replacement.
Gregory M. Larson, Vice President – Accounting & Controller, informed the company of his intention to resign on June 23, 2026
Marcel Teunissen, EVP and CFO since April 6, 2026, is interim principal accounting officer effective June 23, 2026
The company is conducting a search for a permanent Vice President – Accounting & Controller
The filing states no disagreement with the company led to the resignation
Mobility Global appointed Joseph R. Hinrichs as a director, expanding the board from two to three members, effective June 25, 2026. He is expected to become Board Chair when the spin-off from S&P Global takes effect on July 1, 2026, and the filing also covers new CEO pay terms, a new severance plan and new incentive plans.
Joseph R. Hinrichs appointed director effective 11:59 p.m. New York City time on June 25, 2026; expected to become Chair at the spin-off.
Director pay includes an $80,000 annual cash retainer, a $100,000 Chair retainer, a $220,000 annual RSU grant and a one-time $400,000 RSU award.
CEO William Eager's base salary rises to $900,000 and target incentive to 150% of base, effective July 1, 2026, plus a $2,500,000 RSU grant around September 1, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.